LifeMD: Investor Presentation November 2024 NASDAQ: LFMD 9:41 .. Il 令 ■ = Schedule your appointment Today Tomorrow ASAP Jan 23 Jan 24 -20 min wait Dr. Jennell Giles of Any available provider + Schedule an appointment Possible conditions: Middle ear infection Strong evidence Inflamation of external ear 2 Important cautions regarding forward-looking statements This presentation includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended; Section 21E of the S ...

LifeMD, Inc. (NASDAQ:LFMD) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Justin Schreiber – Chairman and Chief Executive Officer Marc Benathen – Chief Financial Officer Conference Call Participants David Larsen - BTIG Sarah James - Cantor Fitzgerald Kyle Bauser - B. Riley Securities Steve Dechert - KeyBanc Eduardo Martinez-Montes - H.C. Wainwright Operator Good afternoon. Thank you for joining us today to discuss LifeMD's Results for the Third Quarter Ended September 30, ...

LifeMD, Inc. (LFMD) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.10. This compares to loss of $0.20 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -40%. A quarter ago, it was expected that this company would post a loss of $0.13 per share when it actually produced a loss of $0.19, delivering a surprise of -46.15%.Over the last four quarters, the company has surpassed co ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Delaware 76-0238453 (State or other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.) Title of each class Trading symbol(s) Name of exchange on which registered Common Stock, par value $.01 per share LFMD The Nasdaq Global Market 8.875% Series A Cumulative Perpetual Preferred Stock, par value $0.0001 per share LFMDP The Nasdaq Global Market Large accelerated filer ☐ Accelerated filer ☒ Non-accelerated f ...

Total revenues increased 38% year-over-year to $53.4 million with telehealth revenue up 65%Record gross margin of 90.6%, up 300 basis points from the year-ago periodAdjusted EBITDA increased 33% to $3.7 millionTelehealth adjusted EBITDA of $2.5 million, a 200% sequential increase versus the second quarterCash of $37.6 million as of September 30, 2024Generated $6.2 million of cash flow from operations in the third quarter and positive net cash flow in each of the last four quarters Conference call begins at ...

LifeMD, Inc.’s (LFMD) Rex MD has launched TestoRx, a direct-to-consumer hormone therapy telehealth service. TestoRx provides an initial consultation with blood tests to pre-screen patients, offering both testosterone replacement and alternative treatments to boost endogenous hormone production. Ongoing telehealth visits and follow-up care are included.Rex MD, a leading men’s telehealth platform, provides virtual medical treatment for various men's health needs, including erectile dysfunction, premature ejac ...

NEW YORK, Sept. 24, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company's 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share. The preferred dividend will be paid on October 15, 2024, to holders of record at the close of business on October 4, 2024. About LifeMD, Inc. LifeMD is a leading provider of virtual ...

Ljupco/iStock via Getty Images Investment Thesis LifeMD, Inc. (NASDAQ:LFMD) reported a mixed Q2 2024 earnings result and guidance. Management states that its non-core asset, WorkSimpli, had some mishaps in Q2, but these aspects are now behind themselves. And yet, this was the same narrative that they provided last quarter. Consequently, I now believe that WorkSimpli has no value. Or better put, I award it no value, as I do not believe management has any ability to monetize its WorkSimpli asset. If LifeMD to ...

NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences during the month of September: H.C. Wainwright 26th Annual Global Investment Conference, September 9-11 at the Lotte New York Palace Hotel. Management will deliver a corporate presentation on Monday, September 9th at 12:00 p.m. Eastern time and will hold one-on-one meetings with investors. TD ...

LifeMD: Investor Presentation August 2024 NASDAQ: LFMD 9:41 "| ~ ■ LifeMD: = Schedule your appointment Today Tomorrow ASAP Jan 23 Jan 24 ~20 min wait Dr. Jennell Giles f Any available provider 十 Schedule an appointment Possible conditions: Middle ear infection Strong evidence Inflamation of external ear Important cautions regarding forward-looking statements This presentation includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended; Section 21E of the S ...